logo

For the Inventor, By the Inventor

Lutherville, MD, United States of America

Aleksander S Popel

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 83(Granted Patents)


Location History:

  • Lutherville, MD (US) (2013 - 2021)
  • Baltimore, MD (US) (2023)
  • Lutherville-Timonium, MD (US) (2017 - 2024)

Company Filing History:

goldMedal14 out of 3,688 
 
Johns Hopkins University
 patents
silverMedal1 out of 1 
 
Asclepix Therapeutics, Inc.
 patent
where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11981754 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2024-05-14),
2. 11674959 - Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors (2023-06-13),
3. 11155603 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases (2021-10-26),
4. 10786463 - Peptide/particle delivery systems (2020-09-29),
5. 10774131 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases (2020-09-15),
6. 10774112 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2020-09-15),
7. 10106597 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases (2018-10-23),
8. 9802984 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2017-10-31),
9. 9717694 - Peptide/particle delivery systems (2017-08-01),
10. 9187544 - Peptide modulators of angiogenesis and use thereof (2015-11-17),
11. 9187539 - Compositions having antiangiogenic activity and uses thereof (2015-11-17),
12. 9056923 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases (2015-06-16),
13. 8557772 - Compositions having antiangiogenic activity and uses thereof (2013-10-15),
14. 8507434 - Peptide modulators of angiogenesis and use thereof (2013-08-13),

Title: Inventor Aleksander S Popel - Revolutionizing Biomedical Engineering

Introduction: Aleksander S Popel is a distinguished inventor based in Lutherville, MD, known for his groundbreaking contributions to the field of biomedical engineering.

Latest Patents: Popel's latest patents focus on innovative drug delivery systems, personalized medicine technologies, and advanced medical imaging devices.

Career Highlights: With a career spanning over three decades, Popel has held key positions in various research institutions and universities, where he has spearheaded numerous projects that have led to significant advancements in healthcare technology.

Collaborations: Popel has collaborated with leading pharmaceutical companies, medical device manufacturers, and academic researchers to translate his innovative ideas into real-world applications. His collaborative approach has resulted in several successful products that have improved patient care globally.

Conclusion: In conclusion, Aleksander S Popel's relentless pursuit of innovation in biomedical engineering has cemented his reputation as a visionary inventor whose work continues to have a profound impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…